The trademark application was filed by Eli Lilly and Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on October 25, 2021, and it was registered by office on February 1, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders and obesity and pharmaceutical preparations..
The mark was filed in class 44 with Medical information services in the field of diabetes, endocrine diseases and disorders, metabolic diseases and disorders and obesity and medical information services..